RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.680
+0.140 (3.08%)
Nov 9, 2026, 10:44 AM EST - Market open

RxSight Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
121.83134.48139.9389.0849.0122.59
Revenue Growth
-14.26%-3.89%57.08%81.77%116.90%53.92%
Gross Profit
92.75103.0198.9453.7721.334.52
Operating Income
-61.46-48.19-36.86-50.09-63.32-52.79
Net Income
-53.36-38.94-27.46-48.61-66.76-48.69
Earnings Per Share
-1.29-0.95-0.71-1.41-2.41-3.57
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
254.68228.13237.22127.18105.8159.33
Total Debt
10.3211.0412.33.014544.93
Net Cash (Debt)
244.36217.09224.93124.1760.81114.4
Net Cash Growth
13.16%-3.48%81.14%104.20%-46.85%199.30%
Net Cash Per Share
5.905.315.793.602.208.40

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
23.67-15.51-16.95-41.59-58.85-44.71
Capital Expenditures
-5.03-3.83-5.44-4.81-2.39-1.94
Free Cash Flow
18.65-19.34-22.39-46.41-61.24-46.65
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
76.13%76.60%70.71%60.36%43.52%19.99%
Operating Margin
-50.44%-35.84%-26.34%-56.23%-129.21%-233.64%
Pretax Margin
-43.69%-28.91%-19.59%-54.55%-136.20%-215.46%
Profit Margin
-43.80%-28.96%-19.62%-54.57%-136.22%-215.50%
FCF Margin
15.30%-14.38%-16.00%-52.10%-124.97%-206.47%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.563.199.9016.237.1713.62